OverviewSuggest Edit

Gencove operates a low-pass genome sequencing platform dedicated to making genomic data more accessible and interpretable through the development of molecular and computational tools. The Company currently offers three products, which include 0.4-fold whole-genome sequencing product, 1x whole-genome sequencing coverage, and a custom designed product that combines one of the low-coverage sequencing products with increased coverage on specific targets.

HQNew York, US

Latest Updates

Employees (est.) (Oct 2020)11
Cybersecurity ratingAMore

Gencove Office Locations

Gencove has an office in New York
New York, US (HQ)
430 E 29th St
Show all (1)

Gencove Financials and Metrics

Summary Metrics

Founding Date


Gencove total Funding

$4 m

Gencove latest funding size

$3 m

Time since last funding

2 years ago

Gencove investors

Gencove's latest funding round in March 2019 was reported to be $3 m. In total, Gencove has raised $4 m
Show all financial metrics

Gencove Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

Gencove Online and Social Media Presence

Embed Graph

Gencove News and Updates

Neogen, Gencove partner to advance animal genomics

LINCOLN, Neb., Jan. 9, 2020 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that it has entered into a partnership with genetic testing company Gencove to develop Neogen's next generation of animal genomic tests. Gencove's flagship product is its low-pass whole genome...

Gencove announces Phase I SBIR grant to validate polygenic risk score estimation from low-pass sequencing

NEW YORK, April 25, 2019 /PRNewswire/ -- Gencove, the leading low-pass sequencing platform announced today the receipt of a Phase I grant from the National Cancer Institute under the auspices of the Small Business Innovation Research (SBIR) program of the National Institutes of Health....

Gencove Blogs

Cleaning up My FASTQs

Users have been telling us they sometimes upload the wrong FASTQ files or give them the wrong names, and would appreciate the ability to clean up “My FASTQs”.To that end, we’ve rolled out a feature that enables users to manually delete uploads that haven’t been assigned to a project:This is the firs…

Population genomics to understand bleaching in corals

This is a guest post by Zach Fuller and Molly Przeworski at Columbia University on how they used low-pass sequencing in the preprint ‘Population genetics of the coral Acropora millepora: Towards a genomic predictor of bleaching’.The symbiotic relationship between corals and photosynthetic algae (fam…

An enterprise-ready software platform for low-pass sequencing analysis

Over the past two years, we at Gencove have launched low-pass sequencing products as a superior alternative to genotyping arrays across species, with applications ranging from genome-wide association studies to molecular breeding.During this time, we’ve seen dramatic decreases in the cost and operat…

Gencove for agricultural species and model organisms

tl;dr: Gencove now supports analysis of low-pass sequencing data from cattle, chickens, pigs, mice, rats, maize, and soybeans.We launched Gencove’s low-pass sequencing platform about a year ago with the goal of making genome sequencing technologies accessible and cost-effective for large-scale genom…
Show more

Gencove Frequently Asked Questions

  • When was Gencove founded?

    Gencove was founded in 2015.

  • How many employees does Gencove have?

    Gencove has 11 employees.

  • Who are Gencove competitors?

    Competitors of Gencove include NeuroTherapia, Nautilus Biotechnology and Navigo Proteins.

  • Where is Gencove headquarters?

    Gencove headquarters is located at 430 E 29th St, New York.

  • Where are Gencove offices?

    Gencove has an office in New York.

  • How many offices does Gencove have?

    Gencove has 1 office.